| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0016-5085(95)90068-3 |
| P698 | PubMed publication ID | 7835582 |
| P2093 | author name string | M Dougados | |
| C Roux | |||
| S Chaussade | |||
| D Couturier | |||
| B Amor | |||
| S Guillemant | |||
| S Kolta | |||
| V Abitbol | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 417-422 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Metabolic bone assessment in patients with inflammatory bowel disease | |
| P478 | volume | 108 |
| Q39029698 | ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease |
| Q34057531 | Advances in inflammatory bowel disease |
| Q37098360 | Adverse bone health among children and adolescents growing up with HIV. |
| Q34698973 | Age-of-onset-dependent influence of NOD2 gene variants on disease behaviour and treatment in Crohn's disease |
| Q34597311 | Bone Disease in Patients With Primary Sclerosing Cholangitis |
| Q77159351 | Bone abnormalities in gastrointestinal and hepatic disease |
| Q50636283 | Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. |
| Q33617853 | Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study |
| Q84776058 | Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease |
| Q30870593 | Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency |
| Q33378962 | Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density |
| Q34497449 | Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D. |
| Q36609650 | Can early onset of disease be one of the risk factors for low bone mineral density in patients with inflammatory bowel disease? |
| Q42342936 | Clinical relevance of changes in bone metabolism in inflammatory bowel disease |
| Q44805370 | Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake |
| Q58868240 | Elevada prevalencia de déficit de vitamina D en poblaciones con riesgo de osteoporosis: un factor relevante en la integridad ósea |
| Q36635099 | Exercise and Crohn's disease: speculations on potential benefits |
| Q35580817 | Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules |
| Q74256124 | Extraintestinal Complications of Inflammatory Bowel Disease |
| Q33866998 | Extraintestinal manifestations and complications in inflammatory bowel diseases |
| Q35358784 | Fracture risk is increased in Crohn's disease, but not in ulcerative colitis |
| Q77195252 | Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease |
| Q27010898 | HIV: inflammation and bone |
| Q38247077 | Health maintenance and inflammatory bowel disease |
| Q84800544 | High Prevalence of Low-Trauma Fracture in Chronic Pancreatitis |
| Q35595126 | High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease |
| Q44835606 | Histomorphometric Analysis Reveals Reduced Bone Mass and Bone Formation in Patients With Quiescent Crohn's Disease |
| Q35255199 | Inflammatory bowel disease and predisposition to osteopenia |
| Q36853309 | Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy |
| Q28360089 | Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? |
| Q35596697 | Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density |
| Q35123938 | Mechanisms by Which Nutritional Disorders Cause Reduced Bone Mass in Adults |
| Q36304174 | Mechanisms of disease: vitamin D and inflammatory bowel disease |
| Q35831980 | Metabolic bone disease and parenteral nutrition |
| Q92485616 | Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain |
| Q41686763 | Multivariate identification of metabolic features in inflammatory bowel disease |
| Q33869248 | Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease |
| Q48895847 | Nutritional consequences and nutrition therapy in Crohn's disease |
| Q36761878 | Nutritional management of Crohn's disease |
| Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
| Q80900224 | Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease |
| Q33765659 | Risk factors for low bone mineral density in children and young adults with Crohn's disease |
| Q79770437 | Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota |
| Q37136913 | Sex-Specific Issues in Inflammatory Bowel Disease |
| Q21090112 | Systematic association mapping identifies NELL1 as a novel IBD disease gene |
| Q35597297 | The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss |
| Q36609666 | The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease. |
| Q34268491 | Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study |
| Q80234067 | [Bone and joints in inflammatory bowel disease] |
| Q81814059 | [Gastrointestinal diseases and osteomalacia] |
Search more.